Home » Topics » Disease categories and therapies » Ear, nose and throat

Ear, nose and throat
RSS

Discovery of a novel enzymatic function of histone deacetylase 11

Aug. 14, 2018

First patients dosed in phase I/II study of FX-322

Aug. 8, 2018

Otonomy initiates additional phase III trial of Otividex for Meniere's disease

July 27, 2018

New phase IIa study aims to confirm absence of anticholinergic effects with seliforant

July 25, 2018

Addition of sodium thiosulfate to cisplatin lowers incidence of cisplatin-induced hearing loss

July 24, 2018

Hearing light, no synesthesia required

July 18, 2018

KCNC1/KCNC2 channel modulators presented by Autifony Therapeutics

July 10, 2018

EMA gives positive scientific advice on development plan and regulatory pathway for AM-111

May 8, 2018

WHO grants INN seliforant to Sensorion's SENS-111

May 3, 2018

Oricula Therapeutics cleared to begin clinical testing of ORC-13661 in U.S.

Feb. 6, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...